A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients-Reference-Cited by-同舟云学术

A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients

Published:2015-04-24 Issue:16 Volume:21 Page:3610-3618
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Lee Eudocia Q.,Kaley Thomas J.,Duda Dan G.,Schiff David,Lassman Andrew B.,Wong Eric T.,Mikkelsen Tom,Purow Benjamin W.,Muzikansky Alona,Ancukiewicz Marek,Huse Jason T.,Ramkissoon Shakti,Drappatz Jan,Norden Andrew D.,Beroukhim Rameen,Weiss Stephanie E.,Alexander Brian M.,McCluskey Christine S.,Gerard Mary,Smith Katrina H.,Jain Rakesh K.,Batchelor Tracy T.,Ligon Keith L.,Wen Patrick Y.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking Hope: Anti-VEGFR inhibitors and their potential in glioblastoma treatment;Critical Reviews in Oncology/Hematology;2024-06

2. Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial;Cancer Biology & Medicine;2024-03-04

3. Safety and Efficacy of Temozolomide Combinations in Glioblastoma Patients; A Meta-Analysis;Research Journal of Biotechnology;2024-02-29

4. Glioblastoma Therapy: Past, Present and Future;International Journal of Molecular Sciences;2024-02-21

5. Cellular signaling in glioblastoma: A molecular and clinical perspective;International Review of Cell and Molecular Biology;2024